Diagnostic and Biotech

Future Horizons and Growth Strategies in the Global Cancer Diagnostics Market 2015: Supplier Shares and Country Forecasts

  • VPG302723
  • 1200 Pages
  • June 2015
  • Diagnostic and Biotech
Complete report $34,750. DataPack (test volumes, sales forecasts, supplier shares) $21,100.


Future Horizons and Growth Strategies in the Global Cancer Diagnostics Market 2015 is a new seven-countrystrategic analysis of the major business opportunities emerging in the cancer diagnostics market during the nextfive years. The report examines trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.



Rationale


The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

Worldwide Market Overview


- Estimated universe of laboratories performing cancer diagnostic testing

by country.


- Five-year test volume and sales projections by country.


Business Opportunities and Strategic Recommendations


- Specific new product development opportunities with potentially

significant market appeal during the next five years.


- Design criteria for new products.


- Alternative market penetration strategies.


- Potential market entry barriers and risks.


Cancer Diagnostic TestsOver 200 current and emerging assays including:


ACTH, AFP, Beta-2 Microglobulin, CA 15-3/27.29, CA 19-9, CA 125, Calcitonin, Cathepsin, CEA,

Chromogranin, Colon-Specific Antigen, Cytokeratins, Estrogen Receptor, Ferritin, Gastrin, HCG,

Insulin, Interferons, Interleukins, Lymphocyte Subtyping, Neuron-Specific Enolase, Nucleolar,

Occult Blood, Oncogenes, Pancreatic Oncofetal Antigen, Pap Smear, Parathyroid Hormone,

Progesterone Receptor, Prostatic Acid Phosphatase, Prostatic Specific Antigen, S-100 Protein,

Serotonin, Sialic Acid, Squamous Cell Carcinoma Ag, TDT, Thymidine Kinase, Thyroglobulin,

Tissue Polypeptide Antigen, and others.


Geographic Coverage


France, Germany,
Italy, Japan,
Spain, UK, USA


Market Segmentation Analysis


- Sales and market shares of major suppliers,

by individual cancer diagnostic test and country.


- Five-year test volume and sales forecasts

for major cancer diagnostic tests

by country and market segment, including:


- Hospitals

- Commercial/Private Laboratories

- Physician Offices/Group Practices

- Cancer Clinics

- Ambulatory Care Centers


- Comprehensive market segmentation analysis, including review

of the market dynamics, structure, size, growth and major suppliers

by country.


- Cancer statistics, etiology and recent developments in the

U.S., Japan and five major European countries.


Current and Emerging Products


- Review of over 200 current and emerging cancer diagnostic tests,

including:


- Biochemical Markers

- Oncogenes

- Growth Factors

- Hormones

- Colony Stimulating Factors

- Lymphokines

- Immunohistochemical Stains, and others.

- Instrumenation review analysis of major immunoassay analyzers used for cancer diagnostic testing, including their operatingcharacteristics, features and selling prices.


Technology Assessment


- Assessment of monoclonal antibodies, immunoassays, DNA

probes, biochips/microarrays, chromosome analysis, IT,

artificial intelligence, flow cytometry, biosensors, and other technologies

and their potential applications for cancer diagnostic testing.


- Review of competing/complementing technologies, including

CT, MRI, NMR, PET and photonics spectroscopy.


- Extensive listings of over 500 companies, universities

and research centers developing new cancer diagnostic tests

and detection technologies.


Competitive Strategies


- Strategic assessments ofmajor suppliers

and start-up firms developing innovative

technologies and products, including their sales,

product portfolios, marketing tactics, collaborative

arrangements, and new products in R&D.


Contains 1,200 pages and 450 tables

Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global C-Reactive Protein Testing Market (Application, Types of Assays and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

C-Reactive Protein Tests are blood tests that measure the levels of C-Reactive Protein. C-reactive protein is a protein that is produced by the liver and its level increase when there ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Live Cell Imaging Market - Opportunities and Forecast, 2014 - 2020

Live cell imaging is the study of cells in real time using the images obtained from screening systems and microscopes. The technology has altered the approach of scientists to study ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Blood Testing Technologies Market (Type, Technology, End User and Geography) - Size, Share, Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2014 - 2020

Testing of blood is one of the oldest and most widely used techniques to rule out the presence of any disease. Blood tests are used to assure the biochemical and ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Label Free Detection Market (Technology, Product, Application, End User and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast 2013 - 2020

The label free detection method is used for detecting biomolecules and their interactions. This method has emerged as an attractive research and development tool in the pharmaceutical and biotech industry. Partnerships between pharmaceutical companies and academic institutes and the rising number of drug discovery programs will boost market growth.

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Oxidative Stress Assay Market - Opportunities and Forecasts, 2015 - 2020

Oxidative stress assay is used to determine level of oxidative stress markers and reagents in cells. Applications of oxidative stress assay are research laboratories and bioproduction. Assays detect generalized oxidative ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Epigenetics Market - Opportunities and Forecasts, 2015 - 2020

Epigenetics, in the field of genetics, involves study of cellular and physiological trait variations initiated by external or ecological aspects which swipe genes on and off and affect how cells ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>